Fresenius Medical Care | FME - Gewinn Vor Steuern

Aktienkurs
38.34
Täglich Wechseln
0.22 0.58%
Monatlich
-2.76%
Jährlich
-28.55%
Q2 Prognose
36.25




Gewinn Vor Steuern Veränderung Datum
Akzo Nobel EUR 148M 598M 2026-03
Alcon AG USD 240M 24M 2026-03
AstraZeneca USD 3.91B 1.28B 2026-03
Bayer EUR -3.37B 2.21B 2025-12
Beiersdorf EUR 408.5M 43.5M 2025-06
DaVita Healthcare Partners USD 341.23M 41.52M 2026-03
Demant DKK 1.64B 173M 2025-12
E.ON EUR 3.63B 2.44B 2026-03
Essilor EUR 2.45B 1.73B 2025-06
Fresenius EUR 601M 122M 2025-12
Fresenius Medical Care EUR 340M 168.46M 2026-03
Genmab DKK 55M 427M 2025-12
Getinge SEK 428M 1.54B 2025-03
Givaudan CHF 642M 292M 2024-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
GN Store Nord DKK 450M 332M 2025-12
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lonza CHF 624M 197M 2024-12
Merck EUR 401M 886.1M 2025-12
Novartis USD 3.84B 802M 2026-03
Philips EUR 466M 191M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
RWE EUR 827M 249M 2025-12
Sanofi EUR -1.16B 5.5B 2025-12
SAP EUR 2.83B 65M 2026-03
Smith & Nephew USD 469M 70M 2025-12